From: Gut colonization with vancomicyn-resistant enterococci among patients with hematologic malignancies
Characteristics | VRE colonized patients | |
---|---|---|
Hospital-acquired | Community-acquired | |
Demographics | ||
 Mean age (years) | 74 | 73 |
 Gender: male: female | 9:4 | 4:1 |
Primary hematologic disease (n) | ||
 Myelodysplastic syndrome | 3 | 3 |
 Non-hodgkin lymphoma | 0 | 1 |
 Multiple myeloma | 7 | 0 |
 Chronic lymphocytic leukemia | 2 | 1 |
Underling diseases (n) | ||
 Chronic heart failure | 9 | 3 |
 Chronic obstructive pulmonary disease | 1 | 1 |
 Chronic renal failure | 2 | 0 |
 Insulin-dependent diabetes mellitus | 5 | 1 |
 Obesity | 2 | 0 |
 Chemotherapy | 8 | 0 |
 Corticosteroids use | 7 | 2 |
Medications prior the hospital admission (н) | ||
 Cardiovascular medications | 9 | 3 |
 Endocrine medications | 6 | 2 |
 COPD medications | 1 | 1 |
 Nonsteroids | 2 | 2 |
 Other medicationsa | 1 | 0 |
Antibiotic use in last 30Â days and during the current hospital stay (n) | ||
 3rd generation cephalosporins | 1 | 2 |
 Fluroquinolones | 1 | 0 |
 Carbapenems | 0 | 1 |
 Vancomycin | 0 | 1 |
 Metronidazole | 0 | 1 |